相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria - An IRMA substudy
Frederik Persson et al.
DIABETES (2006)
Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes - The Hoorn Study
J de Jager et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn study
Frank Stam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
CG Schalkwijk et al.
CLINICAL SCIENCE (2005)
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB Prospective Complications Study
MT Schram et al.
DIABETOLOGIA (2005)
Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study
AS Astrup et al.
KIDNEY INTERNATIONAL (2005)
Combining TGF-β inhibition and angiotensin II blockade results in enhanced antifibrotic effect
L Yu et al.
KIDNEY INTERNATIONAL (2004)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes - Progressive, interrelated, and independently associated with risk of death
CDA Stehouwer et al.
DIABETES (2002)
Angiotensin II and renal fibrosis
SA Mezzano et al.
HYPERTENSION (2001)